skip to main content

AB0347 Validation of the clinical remission criteria in rheumatoid arthritis at keio immunotherapy center

Kaneko, Y. ; Kuwana, M. ; Kameda, H. ; Takeuchi, T.

Annals of the Rheumatic Diseases June 2013, Vol.71(Suppl 3), p.657 [Periódico revisado por pares]

BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
  • Título:
    AB0347 Validation of the clinical remission criteria in rheumatoid arthritis at keio immunotherapy center
  • Autor: Kaneko, Y. ; Kuwana, M. ; Kameda, H. ; Takeuchi, T.
  • É parte de: Annals of the Rheumatic Diseases June 2013, Vol.71(Suppl 3), p.657
  • Descrição: Remission has become the realistic goal in rheumatoid arthritis (RA) with the advent of new therapy including biologic agents. In 2011 ACR/EULAR has developed new definition of remission in RA which can presumably reflect the residual disease activity more accurately. However there is little information regarding the validity and the feasibility of the new definition in clinical practice.
  • Editor: BMJ Publishing Group Ltd and European League Against Rheumatism
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.